SlideShare uma empresa Scribd logo
1 de 40
Chapter 12
Cost, Access, and Quality
Learning Objectives
• Understand:
– health care costs, their trends, and underlying
factors
– why some regulatory cost-containment
approaches were unsuccessful
– nature, scope and dimensions of quality
– the difference between quality assurance and
assessment
Learning Objectives
• Become familiar with regulatory and market-
oriented ways to contain costs
• Appreciate the framework and dimensions of
access to care
• Learn about access indicators and
measurements
• To discuss the implications of the Affordable
Care Act on cost, access, and quality
Introduction
• Three cornerstones of health care delivery:
– Cost
– Access
– Quality
• Uncontrolled expenditures mitigate a nation’s
ability to provide access to quality health care
Introduction
• High quality care
– the most cost-effective care
– cost is important in evaluating quality
– achieved when:
• accessible services are efficient
• cost-effective
• provided in an acceptable manner
Cost of Health Care
• Three meanings:
1) Price: physician’s bill, prescription bill, premiums
2) National perspective: how much a nation spends
on health care (health care expenditures)
3) Provider perspective: cost of production (staff
salaries, capital, supplies)
Trends in National Health Expenditures
• Evaluating national health care expenditures
1) Compared to Consumer Price Index (CPI)
• CPI measures general inflation in the economy
and calculates the annual changes (See Figure
12-2)
2) Compared to Gross Domestic Product (GDP)
• See Figure 12-3
Trends in National Health Expenditures
• U.S. uses a larger percentage of economic resources
on health care
– See Table 12-2
• 2009, 17.4% of GDP was spent on health care
– $7,960 per capita
• 2015, 20% of GDP projected to be spent on health
care
Do We Need to Contain Costs?
• Reasons to control costs:
1) Health care consumes a greater percent of the
total economic output
• Resources are limited
• Other economic uses are curtailed
2) Limited resources should be directed to their
highest value
3) Corporations bear the additional cost of doing
business
4) Public spending for health care will become
unsustainable
Reasons for Cost Escalation
• Medical cost inflation influenced by:
– Third party payment
– Imperfect market
– Growth of technology
– Increase in elderly population
– Medical model of health care delivery
– Multipayer system, administrative costs
– Defensive medicine
– Waste and abuse
– Practice variations
Reasons for Cost Escalation
• Third party payment:
– Moral hazard
– Provider-induced demand
• Imperfect market:
– Health care market in the U.S. is neither free nor
highly regulated, and prices far exceed the cost of
production
– E = Q x P
– In national health care, both Q and P are
controlled by a central agency
– Both remain unchecked in an imperfect market
Reasons for Cost Escalation
• Technology and specialization:
– Beliefs and values
– High R&D spending
– Innovation that leads to utilization
– Surplus of specialists
• Increase in elderly population:
– Increased longevity
– Baby boomers
– The elderly use nearly three times as much health
care as younger people
Reasons for Cost Escalation
• Medical model of health:
–Misplaced emphasis on medical treatments
–Health promotion/disease prevention takes
a back seat
Reasons for Cost Escalation
Multipayer System and Administrative Costs
Inefficiencies
related to:
–financing
–insurance
–delivery
–payment
functions
–enrollment
process
–contracts
–claims processing
–utilization
–denials and
appeals
–marketing
Reasons for Cost Escalation
• Defensive Medicine
– Medical tests and treatments that are not justified, but
done for self-protection
• Waste and Abuse
– Inefficiencies and Fraud
• Knowing disregard of the truth
• A major problem in Medicare and Medicaid
–Unnecessary services may be provided
–Upcoding
–Misallocation of costs to increase reimbursement (in
cost-plus reimbursement systems)
• Receiving kickback for referrals
• Self-referral (Stark Laws)
Reasons for Cost Escalation
• Practice variations (small area variations)
– Signal gross inefficiencies in the system
– Compromise both cost and quality
Cost Containment: Regulatory
Approaches
• All-payer (single-payer) system
• ACA
• Health Planning
• Price Controls
• Peer Review
Cost Containment: Regulatory
Approaches
• All-payer (single-payer) system
– Top-down control (global budgets)
– The U.S. does not have an all-payer system
• Bottom-up cost control
• Cost shifting occurs
• Health Planning
– Government’s efforts to align and distribute
health care resources to achieve health outcomes
– No system-wide planning and controls in the U.S.
• CON planning used by some states
Cost Containment: Regulatory
Approaches
• Price Controls
– Economic Stabilization Program used during the
Nixon presidency
– Provider-induced demand (no control on Q)
mitigated the effects of price controls
– DRG-based PPS shifted costs to the outpatient
sector
– PPS extended to other health care sectors
– Arbitrary rate setting by Medicaid
– Pay for performance
Cost Containment: Regulatory
Approaches
• Peer Review
– Peer Review Organizations (PROs)
• Statewide private organizations
• Review by physicians and other health
professionals
• Paid by federal government
• To review care provided to medicare patients
–Is care reasonable? Necessary? Appropriate?
–Meets quality?
Cost Containment: Regulatory
Approaches
• Peer Review Organizations (PROs)
• Each state has a pro
• Can deny payment if care not necessary or
appropriate
• Pros are now called quality improvement
organizations (qios)
Cost Containment: Competitive
Approaches
• Demand-side Incentives
• Supply-Side Regulation
• Payer-Driven Price Competition
• Utilization Controls
• Competition
–Rivalry among sellers for customers
• Health care competition can be based on
technology, quality, amenities, access
Cost Containment: Competitive
Approaches
• Demand-side incentives
– Cost-sharing by consumers
– A self-rationing mechanism (reduces moral
hazard)
– RAND experiment
• Supply-side regulation
– Antitrust laws
– Anticompetitive practices can be illegal
Cost Containment: Competitive
Approaches
• Payer-driven price competition
– Patients are not customers in the economic sense
• They pay little out of pocket
• They lack technical information
– Payer-driven competition occurs at two levels:
• Employers shop for value in health insurance plans
• Managed care shops for best value from providers
• Utilization controls
– Employed by MCOs
– They overcome the information gap that patients face
Access to Care
• Access:
– Ability to obtain needed, affordable, convenient,
acceptable, and effective personal health services
timely
– Key implications:
• a determinant of health
• a benchmark in assessing effectiveness
• equity
• quality and efficient use of needed services
Access to Care
• Access concepts:
–Does patient have a source of care
• Primary care physician
–Use of health care
• Availability, convenience, referral
–Acceptability of services
• An patient’s preference and values
Access to Care
• Dimensions of Access
– Accessibility: fit between the locations of providers
and patients (transportation, convenience)
– Affordability: ability to pay
– Accommodation: how resources are organized to
provide services and the patient’s ability to use the
services (timely appointments, quick service, walk-ins,
etc)
– Acceptability: compatibility (waiting time; race,
culture, gender, etc.)
Access to Care
• Types of Access
a) potential: capacity, organization, financing
b) realized: type, site, purpose of health services
c) equitable/inequitable: distribution of health care
to patient’s perceived need
d) effective and efficient: links realized access to
health outcomes
• Current Indicators of Access
– Look at Tbl 12-3 and 12-4
– Look at Tbl 12-5
Quality of Care
Institute of Medicine
• Increased likelihood of desired health
outcomes
• Use of current professional knowledge
Quality of Care
Dimensions of quality
• Microview
– Clinical (technical) aspects
– Interpersonal aspects
– Quality of life
• General HRQL
• Disease-specific HRQL
• Institution-related quality of life
• Macroview
– Mortality
– Incidence and prevalence
Quality Assurance
• Based on total quality management (TQM)
– similar to continuous quality improvement (CQI)
and quality improvement (QI)
• A step beyond quality assessment
– cannot occur without quality assessment
• A system-wide commitment to engage in the
improvement of quality on an ongoing basis
Quality Assessment
• Measurement of quality against an
established standard
• Use of data
• Subjective measures must be quantified
• Measurement scales must have
– Validity (extent to which it actually assesses what
it purports to measure)
– Reliability (extent to which same results occur
from repeated applications)
Quality Assessment
• The Donabedian Model
– Structure – the capacity to deliver quality
– Process – how health care is delivered
– Outcome – effects or results obtained
The Donabedian Model
• Structure
– Facilities: license, accreditation
– Equipment
– Staffing levels
– Staff qualifications
– Staff training
– Distribution of hospital beds, physicians, etc. in a
given population
The Donabedian Model
• Process
– Clinical practice guidelines (medical practice
guidelines)
• Evidence-based protocols
• Professional consensus when scientific
evidence is lacking
– Critical pathways
• a timeline
• identifies planned medical interventions
• with expected patient outcomes for a diagnosis
The Donabedian Model Processes
• Cost-efficiency
• Do benefits exceed the costs?
• Underutilization and overutilization are based
on cost efficiency
• Risk management
• Proactive
• Efforts to prevent adverse events related to
clinical care and facility operations
–focused on avoiding medical malpractice
The Donabedian Model
• Outcome
– Bottom-line measure of effectiveness
– Recovery, improved health
– Postoperative infections, nosocomial infections,
iatrogenic illnesses, rehospitalizations
– Malpractice litigation
– Patient satisfaction
– HRQL
Quality Report Cards
• HEDIS
– Health Plan Employer Data and Information Sets
• Standard for reporting quality in managed care
plans
• Measures: effectiveness, access and availability,
satisfaction, health plan stability, utilization,
cost, informed choices
– CMS Program on Quality
– AHRQ Quality Indicators
– State Public Reporting of Hospital Quality
ACA Takeaway
• Cost control measures include competition among
health plans to drive down insurance costs, value-
based purchasing, and reduction in Medicare
payments to providers.
• Promises to increase access to affordable insurance
coverage, and supports improvements in primary
care and wellness.
• Includes some provisions for improving quality of
care, through programs that link payment to quality
outcomes in Medicare, strengthening of the quality
infrastructure, and encouraging the development of
new patient care models.

Mais conteúdo relacionado

Mais procurados

Financing Healthcare (Part 2) Lecture D
Financing Healthcare (Part 2) Lecture DFinancing Healthcare (Part 2) Lecture D
Financing Healthcare (Part 2) Lecture DCMDLearning
 
HIT Standards Committee Trudel CMS Rules
HIT Standards Committee Trudel CMS RulesHIT Standards Committee Trudel CMS Rules
HIT Standards Committee Trudel CMS RulesBrian Ahier
 
Trudel Cms Rules 072810[1]
Trudel Cms Rules 072810[1]Trudel Cms Rules 072810[1]
Trudel Cms Rules 072810[1]nealkanage
 
Working with Regulators: A Focus on CMS | June 24, 2014 | All Slides
Working with Regulators: A Focus on CMS | June 24, 2014 | All SlidesWorking with Regulators: A Focus on CMS | June 24, 2014 | All Slides
Working with Regulators: A Focus on CMS | June 24, 2014 | All SlidesCancerSupportComm
 
Health system strengthening evidence review – A summary of the 2021 update
Health system strengthening evidence review – A summary of the 2021 updateHealth system strengthening evidence review – A summary of the 2021 update
Health system strengthening evidence review – A summary of the 2021 updateReBUILD for Resilience
 
Intro to Economic Evaluation for Family Physicians 2015.2.25
Intro to Economic Evaluation for Family Physicians 2015.2.25Intro to Economic Evaluation for Family Physicians 2015.2.25
Intro to Economic Evaluation for Family Physicians 2015.2.25Borwornsom Leerapan
 
Apami2006 Middleton Value Hi Tv4
Apami2006 Middleton Value Hi Tv4Apami2006 Middleton Value Hi Tv4
Apami2006 Middleton Value Hi Tv4Blackford Middleton
 
Health Technology Assessment- Overview
Health Technology Assessment- OverviewHealth Technology Assessment- Overview
Health Technology Assessment- Overviewshashi sinha
 
MAST and its application in RENEWING HEALTH
MAST and its application in RENEWING HEALTHMAST and its application in RENEWING HEALTH
MAST and its application in RENEWING HEALTHAnna Kotzeva
 
critical pathway & health care reforms
critical pathway & health care reformscritical pathway & health care reforms
critical pathway & health care reformssangeetha antoe
 
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIESOPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIESOffice of Health Economics
 

Mais procurados (15)

Health technology
Health technologyHealth technology
Health technology
 
Financing Healthcare (Part 2) Lecture D
Financing Healthcare (Part 2) Lecture DFinancing Healthcare (Part 2) Lecture D
Financing Healthcare (Part 2) Lecture D
 
Nicholas Mays
Nicholas MaysNicholas Mays
Nicholas Mays
 
HIT Standards Committee Trudel CMS Rules
HIT Standards Committee Trudel CMS RulesHIT Standards Committee Trudel CMS Rules
HIT Standards Committee Trudel CMS Rules
 
Trudel Cms Rules 072810[1]
Trudel Cms Rules 072810[1]Trudel Cms Rules 072810[1]
Trudel Cms Rules 072810[1]
 
Working with Regulators: A Focus on CMS | June 24, 2014 | All Slides
Working with Regulators: A Focus on CMS | June 24, 2014 | All SlidesWorking with Regulators: A Focus on CMS | June 24, 2014 | All Slides
Working with Regulators: A Focus on CMS | June 24, 2014 | All Slides
 
OHE RWE Poster - HTAi Tokyo May 2016
OHE RWE Poster - HTAi Tokyo May 2016OHE RWE Poster - HTAi Tokyo May 2016
OHE RWE Poster - HTAi Tokyo May 2016
 
Health system strengthening evidence review – A summary of the 2021 update
Health system strengthening evidence review – A summary of the 2021 updateHealth system strengthening evidence review – A summary of the 2021 update
Health system strengthening evidence review – A summary of the 2021 update
 
Intro to Economic Evaluation for Family Physicians 2015.2.25
Intro to Economic Evaluation for Family Physicians 2015.2.25Intro to Economic Evaluation for Family Physicians 2015.2.25
Intro to Economic Evaluation for Family Physicians 2015.2.25
 
Apami2006 Middleton Value Hi Tv4
Apami2006 Middleton Value Hi Tv4Apami2006 Middleton Value Hi Tv4
Apami2006 Middleton Value Hi Tv4
 
Health technology
Health technologyHealth technology
Health technology
 
Health Technology Assessment- Overview
Health Technology Assessment- OverviewHealth Technology Assessment- Overview
Health Technology Assessment- Overview
 
MAST and its application in RENEWING HEALTH
MAST and its application in RENEWING HEALTHMAST and its application in RENEWING HEALTH
MAST and its application in RENEWING HEALTH
 
critical pathway & health care reforms
critical pathway & health care reformscritical pathway & health care reforms
critical pathway & health care reforms
 
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIESOPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
OPTIONS FOR FORMULARY DEVELOPMENT IN MIDDLE-INCOME COUNTRIES
 

Destaque (12)

Legal and Ethical Issues Ch02
Legal and Ethical Issues Ch02Legal and Ethical Issues Ch02
Legal and Ethical Issues Ch02
 
Intro.to.course.hit2333 2016
Intro.to.course.hit2333 2016Intro.to.course.hit2333 2016
Intro.to.course.hit2333 2016
 
HIT1443 LEIHP4e Ch11
HIT1443 LEIHP4e Ch11HIT1443 LEIHP4e Ch11
HIT1443 LEIHP4e Ch11
 
DHCA-Chapter8
DHCA-Chapter8DHCA-Chapter8
DHCA-Chapter8
 
ILC_Brand_Guidelines_May2014
ILC_Brand_Guidelines_May2014ILC_Brand_Guidelines_May2014
ILC_Brand_Guidelines_May2014
 
DHCA-Chapter7
DHCA-Chapter7DHCA-Chapter7
DHCA-Chapter7
 
Him tech ch01
Him tech ch01Him tech ch01
Him tech ch01
 
Hit1614 hbhd13e ppt-ch6
Hit1614 hbhd13e ppt-ch6Hit1614 hbhd13e ppt-ch6
Hit1614 hbhd13e ppt-ch6
 
DHCA-Chapter2
DHCA-Chapter2DHCA-Chapter2
DHCA-Chapter2
 
HBHD 13e Ch21
HBHD 13e Ch21HBHD 13e Ch21
HBHD 13e Ch21
 
HBHD13e - Ch16
HBHD13e - Ch16HBHD13e - Ch16
HBHD13e - Ch16
 
HBHD 13e Ch20
HBHD 13e Ch20HBHD 13e Ch20
HBHD 13e Ch20
 

Semelhante a DHCA-Chapter12

Chapter 12Cost, Access, and QualityLearning Ob.docx
Chapter 12Cost, Access, and QualityLearning Ob.docxChapter 12Cost, Access, and QualityLearning Ob.docx
Chapter 12Cost, Access, and QualityLearning Ob.docxcravennichole326
 
Evolving Approaches to Measuring the Value of New Health Technologies in the US
Evolving Approaches to Measuring the Value of New Health Technologies in the USEvolving Approaches to Measuring the Value of New Health Technologies in the US
Evolving Approaches to Measuring the Value of New Health Technologies in the USOffice of Health Economics
 
1.Quality Intro.pptx
1.Quality Intro.pptx1.Quality Intro.pptx
1.Quality Intro.pptxhayatalakoum1
 
Using Clinical Outcome Data to Improve Patient Care
Using Clinical Outcome Data to Improve Patient CareUsing Clinical Outcome Data to Improve Patient Care
Using Clinical Outcome Data to Improve Patient CareBureau of Health Information
 
An Insider's Guide to Working with CMS - Shari Ling
An Insider's Guide to Working with CMS - Shari LingAn Insider's Guide to Working with CMS - Shari Ling
An Insider's Guide to Working with CMS - Shari LingCancerSupportComm
 
Deborah Schaler - EHPR 2014 - Patient Feedback Research
Deborah Schaler - EHPR 2014 - Patient Feedback ResearchDeborah Schaler - EHPR 2014 - Patient Feedback Research
Deborah Schaler - EHPR 2014 - Patient Feedback ResearchDeborah Schaler
 
FCM3 WHO BUILDING BLOCKS.pptx.pdf
FCM3 WHO BUILDING BLOCKS.pptx.pdfFCM3 WHO BUILDING BLOCKS.pptx.pdf
FCM3 WHO BUILDING BLOCKS.pptx.pdfHanakoAranilla1
 
Moving Beyond the QALY in Patient-Centered Value Frameworks: But, in What Di...
Moving  Beyond the QALY in Patient-Centered Value Frameworks: But, in What Di...Moving  Beyond the QALY in Patient-Centered Value Frameworks: But, in What Di...
Moving Beyond the QALY in Patient-Centered Value Frameworks: But, in What Di...Office of Health Economics
 
Quality assurance in health care
Quality assurance in health care Quality assurance in health care
Quality assurance in health care Ankita Kunwar
 
Strategic purchasing - 30 september
Strategic purchasing - 30 september Strategic purchasing - 30 september
Strategic purchasing - 30 september COP_HHA
 
Pharmacoeconomics & pharmacoepidemioology
Pharmacoeconomics &  pharmacoepidemioologyPharmacoeconomics &  pharmacoepidemioology
Pharmacoeconomics & pharmacoepidemioologyDivya singh
 
5s-CQI-TQM For Hospital Quality Improvement
5s-CQI-TQM For Hospital Quality Improvement5s-CQI-TQM For Hospital Quality Improvement
5s-CQI-TQM For Hospital Quality ImprovementZulfiquer Ahmed Amin
 
Eupha 3.challenges and recommendations helen weatherly
Eupha 3.challenges and recommendations helen weatherlyEupha 3.challenges and recommendations helen weatherly
Eupha 3.challenges and recommendations helen weatherlyDiseaseprevention
 
Transitioning to Value Based Care: Tennessee Oncology, A Case Study
Transitioning to Value Based Care: Tennessee Oncology, A Case StudyTransitioning to Value Based Care: Tennessee Oncology, A Case Study
Transitioning to Value Based Care: Tennessee Oncology, A Case StudyWes Chapman
 
Best Practices for Enabling HIE and Incorporating Capabilities into EHR Workf...
Best Practices for Enabling HIE and Incorporating Capabilities into EHR Workf...Best Practices for Enabling HIE and Incorporating Capabilities into EHR Workf...
Best Practices for Enabling HIE and Incorporating Capabilities into EHR Workf...Justin Campbell
 
Getting evidence from economic evaluation into healthcare practice
Getting evidence from economic evaluation into healthcare practiceGetting evidence from economic evaluation into healthcare practice
Getting evidence from economic evaluation into healthcare practicecheweb1
 

Semelhante a DHCA-Chapter12 (20)

Chapter 12Cost, Access, and QualityLearning Ob.docx
Chapter 12Cost, Access, and QualityLearning Ob.docxChapter 12Cost, Access, and QualityLearning Ob.docx
Chapter 12Cost, Access, and QualityLearning Ob.docx
 
Evolving Approaches to Measuring the Value of New Health Technologies in the US
Evolving Approaches to Measuring the Value of New Health Technologies in the USEvolving Approaches to Measuring the Value of New Health Technologies in the US
Evolving Approaches to Measuring the Value of New Health Technologies in the US
 
Chapter 6
Chapter 6Chapter 6
Chapter 6
 
1.Quality Intro.pptx
1.Quality Intro.pptx1.Quality Intro.pptx
1.Quality Intro.pptx
 
DHCA-Chapter1
DHCA-Chapter1DHCA-Chapter1
DHCA-Chapter1
 
Using Clinical Outcome Data to Improve Patient Care
Using Clinical Outcome Data to Improve Patient CareUsing Clinical Outcome Data to Improve Patient Care
Using Clinical Outcome Data to Improve Patient Care
 
An Insider's Guide to Working with CMS - Shari Ling
An Insider's Guide to Working with CMS - Shari LingAn Insider's Guide to Working with CMS - Shari Ling
An Insider's Guide to Working with CMS - Shari Ling
 
Deborah Schaler - EHPR 2014 - Patient Feedback Research
Deborah Schaler - EHPR 2014 - Patient Feedback ResearchDeborah Schaler - EHPR 2014 - Patient Feedback Research
Deborah Schaler - EHPR 2014 - Patient Feedback Research
 
FCM3 WHO BUILDING BLOCKS.pptx.pdf
FCM3 WHO BUILDING BLOCKS.pptx.pdfFCM3 WHO BUILDING BLOCKS.pptx.pdf
FCM3 WHO BUILDING BLOCKS.pptx.pdf
 
Collaborative Healthcare Models
Collaborative Healthcare ModelsCollaborative Healthcare Models
Collaborative Healthcare Models
 
Moving Beyond the QALY in Patient-Centered Value Frameworks: But, in What Di...
Moving  Beyond the QALY in Patient-Centered Value Frameworks: But, in What Di...Moving  Beyond the QALY in Patient-Centered Value Frameworks: But, in What Di...
Moving Beyond the QALY in Patient-Centered Value Frameworks: But, in What Di...
 
Quality assurance in health care
Quality assurance in health care Quality assurance in health care
Quality assurance in health care
 
Dr. Lemeneh Tefera
Dr. Lemeneh TeferaDr. Lemeneh Tefera
Dr. Lemeneh Tefera
 
Strategic purchasing - 30 september
Strategic purchasing - 30 september Strategic purchasing - 30 september
Strategic purchasing - 30 september
 
Pharmacoeconomics & pharmacoepidemioology
Pharmacoeconomics &  pharmacoepidemioologyPharmacoeconomics &  pharmacoepidemioology
Pharmacoeconomics & pharmacoepidemioology
 
5s-CQI-TQM For Hospital Quality Improvement
5s-CQI-TQM For Hospital Quality Improvement5s-CQI-TQM For Hospital Quality Improvement
5s-CQI-TQM For Hospital Quality Improvement
 
Eupha 3.challenges and recommendations helen weatherly
Eupha 3.challenges and recommendations helen weatherlyEupha 3.challenges and recommendations helen weatherly
Eupha 3.challenges and recommendations helen weatherly
 
Transitioning to Value Based Care: Tennessee Oncology, A Case Study
Transitioning to Value Based Care: Tennessee Oncology, A Case StudyTransitioning to Value Based Care: Tennessee Oncology, A Case Study
Transitioning to Value Based Care: Tennessee Oncology, A Case Study
 
Best Practices for Enabling HIE and Incorporating Capabilities into EHR Workf...
Best Practices for Enabling HIE and Incorporating Capabilities into EHR Workf...Best Practices for Enabling HIE and Incorporating Capabilities into EHR Workf...
Best Practices for Enabling HIE and Incorporating Capabilities into EHR Workf...
 
Getting evidence from economic evaluation into healthcare practice
Getting evidence from economic evaluation into healthcare practiceGetting evidence from economic evaluation into healthcare practice
Getting evidence from economic evaluation into healthcare practice
 

Último

Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)lakshayb543
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4JOYLYNSAMANIEGO
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management SystemChristalin Nelson
 
ROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxVanesaIglesias10
 
Narcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfNarcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfPrerana Jadhav
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptxmary850239
 
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnvESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnvRicaMaeCastro1
 
Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Seán Kennedy
 
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptxBIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptxSayali Powar
 
Active Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfActive Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfPatidar M
 
Oppenheimer Film Discussion for Philosophy and Film
Oppenheimer Film Discussion for Philosophy and FilmOppenheimer Film Discussion for Philosophy and Film
Oppenheimer Film Discussion for Philosophy and FilmStan Meyer
 
Using Grammatical Signals Suitable to Patterns of Idea Development
Using Grammatical Signals Suitable to Patterns of Idea DevelopmentUsing Grammatical Signals Suitable to Patterns of Idea Development
Using Grammatical Signals Suitable to Patterns of Idea Developmentchesterberbo7
 
Reading and Writing Skills 11 quarter 4 melc 1
Reading and Writing Skills 11 quarter 4 melc 1Reading and Writing Skills 11 quarter 4 melc 1
Reading and Writing Skills 11 quarter 4 melc 1GloryAnnCastre1
 
Q-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITWQ-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITWQuiz Club NITW
 
Mental Health Awareness - a toolkit for supporting young minds
Mental Health Awareness - a toolkit for supporting young mindsMental Health Awareness - a toolkit for supporting young minds
Mental Health Awareness - a toolkit for supporting young mindsPooky Knightsmith
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfJemuel Francisco
 
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...DhatriParmar
 

Último (20)

Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
 
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptxINCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
 
prashanth updated resume 2024 for Teaching Profession
prashanth updated resume 2024 for Teaching Professionprashanth updated resume 2024 for Teaching Profession
prashanth updated resume 2024 for Teaching Profession
 
Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4Daily Lesson Plan in Mathematics Quarter 4
Daily Lesson Plan in Mathematics Quarter 4
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management System
 
ROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptxROLES IN A STAGE PRODUCTION in arts.pptx
ROLES IN A STAGE PRODUCTION in arts.pptx
 
Narcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdfNarcotic and Non Narcotic Analgesic..pdf
Narcotic and Non Narcotic Analgesic..pdf
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx
 
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnvESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
ESP 4-EDITED.pdfmmcncncncmcmmnmnmncnmncmnnjvnnv
 
Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...Student Profile Sample - We help schools to connect the data they have, with ...
Student Profile Sample - We help schools to connect the data they have, with ...
 
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptxBIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
BIOCHEMISTRY-CARBOHYDRATE METABOLISM CHAPTER 2.pptx
 
Active Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdfActive Learning Strategies (in short ALS).pdf
Active Learning Strategies (in short ALS).pdf
 
Mattingly "AI & Prompt Design: Large Language Models"
Mattingly "AI & Prompt Design: Large Language Models"Mattingly "AI & Prompt Design: Large Language Models"
Mattingly "AI & Prompt Design: Large Language Models"
 
Oppenheimer Film Discussion for Philosophy and Film
Oppenheimer Film Discussion for Philosophy and FilmOppenheimer Film Discussion for Philosophy and Film
Oppenheimer Film Discussion for Philosophy and Film
 
Using Grammatical Signals Suitable to Patterns of Idea Development
Using Grammatical Signals Suitable to Patterns of Idea DevelopmentUsing Grammatical Signals Suitable to Patterns of Idea Development
Using Grammatical Signals Suitable to Patterns of Idea Development
 
Reading and Writing Skills 11 quarter 4 melc 1
Reading and Writing Skills 11 quarter 4 melc 1Reading and Writing Skills 11 quarter 4 melc 1
Reading and Writing Skills 11 quarter 4 melc 1
 
Q-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITWQ-Factor General Quiz-7th April 2024, Quiz Club NITW
Q-Factor General Quiz-7th April 2024, Quiz Club NITW
 
Mental Health Awareness - a toolkit for supporting young minds
Mental Health Awareness - a toolkit for supporting young mindsMental Health Awareness - a toolkit for supporting young minds
Mental Health Awareness - a toolkit for supporting young minds
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
 
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
Beauty Amidst the Bytes_ Unearthing Unexpected Advantages of the Digital Wast...
 

DHCA-Chapter12

  • 1.
  • 3. Learning Objectives • Understand: – health care costs, their trends, and underlying factors – why some regulatory cost-containment approaches were unsuccessful – nature, scope and dimensions of quality – the difference between quality assurance and assessment
  • 4. Learning Objectives • Become familiar with regulatory and market- oriented ways to contain costs • Appreciate the framework and dimensions of access to care • Learn about access indicators and measurements • To discuss the implications of the Affordable Care Act on cost, access, and quality
  • 5. Introduction • Three cornerstones of health care delivery: – Cost – Access – Quality • Uncontrolled expenditures mitigate a nation’s ability to provide access to quality health care
  • 6. Introduction • High quality care – the most cost-effective care – cost is important in evaluating quality – achieved when: • accessible services are efficient • cost-effective • provided in an acceptable manner
  • 7. Cost of Health Care • Three meanings: 1) Price: physician’s bill, prescription bill, premiums 2) National perspective: how much a nation spends on health care (health care expenditures) 3) Provider perspective: cost of production (staff salaries, capital, supplies)
  • 8. Trends in National Health Expenditures • Evaluating national health care expenditures 1) Compared to Consumer Price Index (CPI) • CPI measures general inflation in the economy and calculates the annual changes (See Figure 12-2) 2) Compared to Gross Domestic Product (GDP) • See Figure 12-3
  • 9. Trends in National Health Expenditures • U.S. uses a larger percentage of economic resources on health care – See Table 12-2 • 2009, 17.4% of GDP was spent on health care – $7,960 per capita • 2015, 20% of GDP projected to be spent on health care
  • 10. Do We Need to Contain Costs? • Reasons to control costs: 1) Health care consumes a greater percent of the total economic output • Resources are limited • Other economic uses are curtailed 2) Limited resources should be directed to their highest value 3) Corporations bear the additional cost of doing business 4) Public spending for health care will become unsustainable
  • 11. Reasons for Cost Escalation • Medical cost inflation influenced by: – Third party payment – Imperfect market – Growth of technology – Increase in elderly population – Medical model of health care delivery – Multipayer system, administrative costs – Defensive medicine – Waste and abuse – Practice variations
  • 12. Reasons for Cost Escalation • Third party payment: – Moral hazard – Provider-induced demand • Imperfect market: – Health care market in the U.S. is neither free nor highly regulated, and prices far exceed the cost of production – E = Q x P – In national health care, both Q and P are controlled by a central agency – Both remain unchecked in an imperfect market
  • 13. Reasons for Cost Escalation • Technology and specialization: – Beliefs and values – High R&D spending – Innovation that leads to utilization – Surplus of specialists • Increase in elderly population: – Increased longevity – Baby boomers – The elderly use nearly three times as much health care as younger people
  • 14. Reasons for Cost Escalation • Medical model of health: –Misplaced emphasis on medical treatments –Health promotion/disease prevention takes a back seat
  • 15. Reasons for Cost Escalation Multipayer System and Administrative Costs Inefficiencies related to: –financing –insurance –delivery –payment functions –enrollment process –contracts –claims processing –utilization –denials and appeals –marketing
  • 16. Reasons for Cost Escalation • Defensive Medicine – Medical tests and treatments that are not justified, but done for self-protection • Waste and Abuse – Inefficiencies and Fraud • Knowing disregard of the truth • A major problem in Medicare and Medicaid –Unnecessary services may be provided –Upcoding –Misallocation of costs to increase reimbursement (in cost-plus reimbursement systems) • Receiving kickback for referrals • Self-referral (Stark Laws)
  • 17. Reasons for Cost Escalation • Practice variations (small area variations) – Signal gross inefficiencies in the system – Compromise both cost and quality
  • 18. Cost Containment: Regulatory Approaches • All-payer (single-payer) system • ACA • Health Planning • Price Controls • Peer Review
  • 19. Cost Containment: Regulatory Approaches • All-payer (single-payer) system – Top-down control (global budgets) – The U.S. does not have an all-payer system • Bottom-up cost control • Cost shifting occurs • Health Planning – Government’s efforts to align and distribute health care resources to achieve health outcomes – No system-wide planning and controls in the U.S. • CON planning used by some states
  • 20. Cost Containment: Regulatory Approaches • Price Controls – Economic Stabilization Program used during the Nixon presidency – Provider-induced demand (no control on Q) mitigated the effects of price controls – DRG-based PPS shifted costs to the outpatient sector – PPS extended to other health care sectors – Arbitrary rate setting by Medicaid – Pay for performance
  • 21. Cost Containment: Regulatory Approaches • Peer Review – Peer Review Organizations (PROs) • Statewide private organizations • Review by physicians and other health professionals • Paid by federal government • To review care provided to medicare patients –Is care reasonable? Necessary? Appropriate? –Meets quality?
  • 22. Cost Containment: Regulatory Approaches • Peer Review Organizations (PROs) • Each state has a pro • Can deny payment if care not necessary or appropriate • Pros are now called quality improvement organizations (qios)
  • 23. Cost Containment: Competitive Approaches • Demand-side Incentives • Supply-Side Regulation • Payer-Driven Price Competition • Utilization Controls • Competition –Rivalry among sellers for customers • Health care competition can be based on technology, quality, amenities, access
  • 24. Cost Containment: Competitive Approaches • Demand-side incentives – Cost-sharing by consumers – A self-rationing mechanism (reduces moral hazard) – RAND experiment • Supply-side regulation – Antitrust laws – Anticompetitive practices can be illegal
  • 25. Cost Containment: Competitive Approaches • Payer-driven price competition – Patients are not customers in the economic sense • They pay little out of pocket • They lack technical information – Payer-driven competition occurs at two levels: • Employers shop for value in health insurance plans • Managed care shops for best value from providers • Utilization controls – Employed by MCOs – They overcome the information gap that patients face
  • 26. Access to Care • Access: – Ability to obtain needed, affordable, convenient, acceptable, and effective personal health services timely – Key implications: • a determinant of health • a benchmark in assessing effectiveness • equity • quality and efficient use of needed services
  • 27. Access to Care • Access concepts: –Does patient have a source of care • Primary care physician –Use of health care • Availability, convenience, referral –Acceptability of services • An patient’s preference and values
  • 28. Access to Care • Dimensions of Access – Accessibility: fit between the locations of providers and patients (transportation, convenience) – Affordability: ability to pay – Accommodation: how resources are organized to provide services and the patient’s ability to use the services (timely appointments, quick service, walk-ins, etc) – Acceptability: compatibility (waiting time; race, culture, gender, etc.)
  • 29. Access to Care • Types of Access a) potential: capacity, organization, financing b) realized: type, site, purpose of health services c) equitable/inequitable: distribution of health care to patient’s perceived need d) effective and efficient: links realized access to health outcomes • Current Indicators of Access – Look at Tbl 12-3 and 12-4 – Look at Tbl 12-5
  • 30. Quality of Care Institute of Medicine • Increased likelihood of desired health outcomes • Use of current professional knowledge
  • 31. Quality of Care Dimensions of quality • Microview – Clinical (technical) aspects – Interpersonal aspects – Quality of life • General HRQL • Disease-specific HRQL • Institution-related quality of life • Macroview – Mortality – Incidence and prevalence
  • 32. Quality Assurance • Based on total quality management (TQM) – similar to continuous quality improvement (CQI) and quality improvement (QI) • A step beyond quality assessment – cannot occur without quality assessment • A system-wide commitment to engage in the improvement of quality on an ongoing basis
  • 33. Quality Assessment • Measurement of quality against an established standard • Use of data • Subjective measures must be quantified • Measurement scales must have – Validity (extent to which it actually assesses what it purports to measure) – Reliability (extent to which same results occur from repeated applications)
  • 34. Quality Assessment • The Donabedian Model – Structure – the capacity to deliver quality – Process – how health care is delivered – Outcome – effects or results obtained
  • 35. The Donabedian Model • Structure – Facilities: license, accreditation – Equipment – Staffing levels – Staff qualifications – Staff training – Distribution of hospital beds, physicians, etc. in a given population
  • 36. The Donabedian Model • Process – Clinical practice guidelines (medical practice guidelines) • Evidence-based protocols • Professional consensus when scientific evidence is lacking – Critical pathways • a timeline • identifies planned medical interventions • with expected patient outcomes for a diagnosis
  • 37. The Donabedian Model Processes • Cost-efficiency • Do benefits exceed the costs? • Underutilization and overutilization are based on cost efficiency • Risk management • Proactive • Efforts to prevent adverse events related to clinical care and facility operations –focused on avoiding medical malpractice
  • 38. The Donabedian Model • Outcome – Bottom-line measure of effectiveness – Recovery, improved health – Postoperative infections, nosocomial infections, iatrogenic illnesses, rehospitalizations – Malpractice litigation – Patient satisfaction – HRQL
  • 39. Quality Report Cards • HEDIS – Health Plan Employer Data and Information Sets • Standard for reporting quality in managed care plans • Measures: effectiveness, access and availability, satisfaction, health plan stability, utilization, cost, informed choices – CMS Program on Quality – AHRQ Quality Indicators – State Public Reporting of Hospital Quality
  • 40. ACA Takeaway • Cost control measures include competition among health plans to drive down insurance costs, value- based purchasing, and reduction in Medicare payments to providers. • Promises to increase access to affordable insurance coverage, and supports improvements in primary care and wellness. • Includes some provisions for improving quality of care, through programs that link payment to quality outcomes in Medicare, strengthening of the quality infrastructure, and encouraging the development of new patient care models.